Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 114,109 | 9,698 | 8,466 | 7,470 | 30,067 |
| Gross Profit | 114,109 | 9,698 | 8,466 | 7,470 | 30,067 |
| Operating Expenses | 131,554 | 136,509 | 128,617 | 126,756 | 130,104 |
| Operating Income | -17,445 | -126,811 | -120,151 | -119,286 | -100,037 |
| Other Income | 261,742 | 14,083 | 17,860 | 10,016 | 9,683 |
| Pre-tax Income | 244,297 | -112,728 | -102,291 | -109,270 | -90,354 |
| Net Income Continuous | 244,297 | -112,728 | -102,291 | -109,270 | -90,354 |
| Net Income | $244,297 | $-112,728 | $-102,291 | $-109,270 | $-90,354 |
| EPS Basic Total Ops | 2.53 | -1.10 | -1.00 | -1.24 | -1.09 |
| EPS Basic Continuous Ops | 2.54 | -1.10 | -1.00 | -1.24 | -1.09 |
| EPS Diluted Total Ops | 2.53 | -1.10 | -1.00 | -1.24 | -1.09 |
| EPS Diluted Continuous Ops | 2.54 | -1.10 | -1.00 | -1.24 | -1.09 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.10 | -1.00 | -1.24 | -1.09 |
| EBITDA(a) | $-15,035 | $-125,484 | $-119,231 | $-117,607 | $-99,234 |